Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (unaudited)

v3.20.1
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
Mar. 31, 2020
Jun. 30, 2019
Current assets    
Cash $ 14,309,996 $ 21,867,289
Restricted cash 500,000 500,000
Accounts receivable, net 1,324,051 1,257,274
Prepaid expenses and other current assets 1,762,371 577,674
Total current assets 17,896,418 24,202,237
Intangible and other assets 23,136,584
Fixed assets, net 65,582
Investment 250,000
Total assets 41,348,584 24,202,237
Current liabilities    
Accounts payable and accrued liabilities 4,025,199 1,818,116
Deferred revenue 743,317 624,387
Total current liabilities 4,768,516 2,442,503
Commitments and contingencies (Note 6)
Equity:    
Preferred stock, par value $0.0001; 5,000,000 shares authorized, none are issued and outstanding at March 31, 2020 and June 30, 2019
Common stock, par value $0.0001; 75,000,000 shares authorized, 12,856,302 issued and outstanding at March 31, 2020, and 10,589,746 shares issued and outstanding at June 30, 2019 1,286 1,059
Additional paid-in capital 69,916,857 47,325,421
Accumulated deficit (38,100,333) (25,566,746)
Total stockholders' equity 31,817,810 21,759,734
Noncontrolling interests in consolidated subsidiary 4,762,258
Total equity 36,580,068 21,759,734
Total liabilities and equity $ 41,348,584 $ 24,202,237